Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
BMJ Case Reports|April 8, 2021
Abnormal movements and diaphragmatic flutter in a case of suspected induced illnessRebecca Arvier, Thomas Clayton, Monique Dade, et al.
Chemical Science|August 30, 2024
A thermophysical investigation of weakly coordinated metals in ionic liquidsCoby J Clarke, Thomas Clayton, Matthew J Palmer, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 25, 2021
Profiling CELMoD-Mediated Degradation of Cereblon NeosubstratesJoel W Thompson, Thomas Clayton, Gody Khambatta, et al.
Nature Structural & Molecular Biology|April 7, 2020
Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complexMary E Matyskiela, Thomas Clayton, Xinde Zheng, et al.
ACS Chemical Biology|November 18, 2020
Cereblon Modulators Target ZBTB16 and Its Oncogenic Fusion Partners for Degradation via Distinct Structural DegronsMary E Matyskiela, Jinyi Zhu, Joshua M Baughman, et al.
Biological Psychiatry|February 1, 2016
Addiction-like Synaptic Impairments in Diet-Induced ObesityRobyn Mary Brown, Yonatan Michael Kupchik, Sade Spencer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2015
Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cellsYohei Hayashi, Laura Caboni, Debanu Das, et al.
Nature Chemical Biology|September 8, 2018
SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrateMary E Matyskiela, Suzana Couto, Xinde Zheng, et al.
Blood Cancer Discovery|May 24, 2021
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignanciesAline Renneville, Jessica A Gasser, Daniel E Grinshpun, et al.
Blood|November 16, 2020
CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cellsChristine Surka, Liqing Jin, Nathan Mbong, et al.
Pageof 5